The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 08, 2019

Filed:

Dec. 11, 2013
Applicant:

Korea Advanced Institute of Science and Technology, Daejeon, KR;

Inventors:

Yong-Mahn Han, Daejeon, KR;

Kyu-Min Han, Daejeon, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/00 (2006.01); C12N 5/02 (2006.01); C12Q 1/68 (2018.01); C12N 5/074 (2010.01); G01N 33/50 (2006.01); C12Q 1/6881 (2018.01); C12Q 1/6883 (2018.01); C12N 5/079 (2010.01);
U.S. Cl.
CPC ...
C12N 5/0696 (2013.01); C12N 5/0618 (2013.01); C12Q 1/6881 (2013.01); C12Q 1/6883 (2013.01); G01N 33/5073 (2013.01); C12N 2503/00 (2013.01); C12N 2506/45 (2013.01); C12Q 2600/158 (2013.01);
Abstract

The present invention relates to an induced pluripotent stem cell (iPS) model for cardiofaciocutaneous (CFC) syndrome, a method for producing the model, and uses of the iPS model in the analysis of neural development in CFC syndrome. Specifically, the CFC syndrome-derived iPS and generation and differentiation of an embryonic body were induced from the fibroblasts of a CFC syndrome patient, and the CFC syndrome-derived iPS and embryonic body were confirmed to exhibit broken embryonic body shapes and no differentiation into neurons. When a CFC syndrome-derived embryonic body was induced by treating with p-ERK and p-SMAD1 inhibitors, the embryonic body exhibited a normal embryonic body shape and effectively differentiated into neurons. Thus, the CFC syndrome patient-derived stem cell model of the invention can be effectively used in the research for neural development in cardiofaciocutaneous syndrome.


Find Patent Forward Citations

Loading…